126 related articles for article (PubMed ID: 33800974)
1.
Li AY; Kashanian SM; Hambley BC; Zacholski K; Duong VH; El Chaer F; Holtzman NG; Gojo I; Webster JA; Norsworthy KJ; Smith BD; DeZern AE; Levis MJ; Baer MR; Kamangar F; Ghiaur G; Emadi A
Biology (Basel); 2021 Mar; 10(3):. PubMed ID: 33800974
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence and clinical significance of FLT3 mutations in acute promyelocytic leukemia].
Xue MX; Qiu HY; Feng YF; Zhu ZL; Chang WR; Liang JY; Chen SN; Cen JN; Xue YQ; Liu YJ; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):757-61. PubMed ID: 19176014
[TBL] [Abstract][Full Text] [Related]
3. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
Lucena-Araujo AR; Kim HT; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone CS; Lima AS; Ruiz-Argüelles G; Undurraga MS; Martinez L; Kwaan HC; Gallagher R; Niemeyer CM; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
Ann Hematol; 2014 Dec; 93(12):2001-10. PubMed ID: 24981688
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of bcr-1 and bcr-3 Isoforms of PML-RARA and FLT3-ITD in Patients With Acute Promyelocytic Leukemia.
Rasekh EO; Elsayed GM; Madney Y; El Gammal MM
Clin Lymphoma Myeloma Leuk; 2020 Mar; 20(3):156-167. PubMed ID: 32033928
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.
Callens C; Chevret S; Cayuela JM; Cassinat B; Raffoux E; de Botton S; Thomas X; Guerci A; Fegueux N; Pigneux A; Stoppa AM; Lamy T; Rigal-Huguet F; Vekhoff A; Meyer-Monard S; Ferrand A; Sanz M; Chomienne C; Fenaux P; Dombret H;
Leukemia; 2005 Jul; 19(7):1153-60. PubMed ID: 15889156
[TBL] [Abstract][Full Text] [Related]
6. [FLT3-ITD Mutation in Newly Diagnosed Patients with Acute Promyelocytic Leukemia].
Gong BF; Wang Y; Lin D; Wei H; Li W; Zhou CL; Liu BC; Liu KQ; Zhang GJ; Liu YT; Li Y; Wei SN; Gong XY; Zhao XL; Qiu SW; Gu RX; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1615-1621. PubMed ID: 28024465
[TBL] [Abstract][Full Text] [Related]
7. Potential Effects of the FLT3-ITD Mutation on Chemotherapy Response and Prognosis of Acute Promyelocytic Leukemia.
Song YH; Peng P; Qiao C; Li JY; Long QQ; Lu H
Cancer Manag Res; 2021; 13():2371-2378. PubMed ID: 33737834
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD.
Ho AD; Schetelig J; Bochtler T; Schaich M; Schäfer-Eckart K; Hänel M; Rösler W; Einsele H; Kaufmann M; Serve H; Berdel WE; Stelljes M; Mayer J; Reichle A; Baldus CD; Schmitz N; Kramer M; Röllig C; Bornhäuser M; Thiede C; Ehninger G;
Biol Blood Marrow Transplant; 2016 Mar; 22(3):462-9. PubMed ID: 26551637
[TBL] [Abstract][Full Text] [Related]
9. Inferior prognostic outcome in acute promyelocytic leukemia with alterations of FLT3 gene.
Yoo SJ; Park CJ; Jang S; Seo EJ; Lee KH; Chi HS
Leuk Lymphoma; 2006 Sep; 47(9):1788-93. PubMed ID: 17064989
[TBL] [Abstract][Full Text] [Related]
10. Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.
Gale RE; Hills R; Pizzey AR; Kottaridis PD; Swirsky D; Gilkes AF; Nugent E; Mills KI; Wheatley K; Solomon E; Burnett AK; Linch DC; Grimwade D;
Blood; 2005 Dec; 106(12):3768-76. PubMed ID: 16105978
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcome of all-trans retinoic acid/anthracycline combination chemotherapy and the prognostic impact of FLT3/ITD mutation in acute promyelocytic leukemia patients.
Hong SD; Kim YK; Kim HN; Lee SR; Ahn JS; Yang DH; Lee JJ; Lee IK; Shin MG; Kim HJ
Korean J Hematol; 2011 Mar; 46(1):24-30. PubMed ID: 21461300
[TBL] [Abstract][Full Text] [Related]
12. FLT3/ITD associated with an immature immunophenotype in PML-RARα leukemia.
Takenokuchi M; Kawano S; Nakamachi Y; Sakota Y; Syampurnawati M; Saigo K; Tatsumi E; Kumagai S
Hematol Rep; 2012 Nov; 4(4):e22. PubMed ID: 23355940
[TBL] [Abstract][Full Text] [Related]
13. Favorable outcome of
Bafail MA; AlTahan R; Samman MA; Tashkandi SA; Motabi IH; Peer-Zada AA
Clin Case Rep; 2023 Jul; 11(7):e07637. PubMed ID: 37426684
[TBL] [Abstract][Full Text] [Related]
14. [The analysis of prognosis-associated factors in adults with acute promyelocytic leukemia].
Ma RJ; Zhu ZM; Yuan XL; Jiang L; Yang SW; Yang J; Guo JM; Shi J; Lei PC; Zhang L; Shang BJ; Sun K; Zhai YP; Li W; Zhang Y
Zhonghua Xue Ye Xue Za Zhi; 2017 Jul; 38(7):592-596. PubMed ID: 28810326
[No Abstract] [Full Text] [Related]
15. Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia.
Shih LY; Kuo MC; Liang DC; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Lai CL
Cancer; 2003 Sep; 98(6):1206-16. PubMed ID: 12973844
[TBL] [Abstract][Full Text] [Related]
16. Correlation between FLT3-ITD status and clinical, cellular and molecular profiles in promyelocytic acute leukemias.
Souza Melo CP; Campos CB; Dutra ÁP; Neto JC; Fenelon AJ; Neto AH; Carbone EK; Pianovski MA; Ferreira AC; Assumpcão JG
Leuk Res; 2015 Feb; 39(2):131-7. PubMed ID: 25530565
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features and prognostic factors in adult acute myeloid leukemia patients with FLT3-ITD and CEBPA gene co-mutation].
Pei RR; Zhang RH; Yu JF; Jiang ZX; Sun H; Wan DM; Xie XS; Liu YF; Li T; Sun L
Zhonghua Xue Ye Xue Za Zhi; 2020 Apr; 41(4):297-301. PubMed ID: 32447933
[No Abstract] [Full Text] [Related]
18. The Impact of
Picharski GL; Andrade DP; Fabro ALMR; Lenzi L; Tonin FS; Ribeiro RC; Figueiredo BC
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31492033
[TBL] [Abstract][Full Text] [Related]
19. The prognosis predictive value of FMS-like tyrosine kinase 3-internal tandem duplications mutant allelic ratio (FLT3-ITD MR) in patients with acute myeloid leukemia detected by GeneScan.
Lyu M; Liao H; Shuai X; Jin Y; Su J; Zheng Q
Gene; 2020 Feb; 726():144195. PubMed ID: 31669649
[TBL] [Abstract][Full Text] [Related]
20. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
